SCARONI, CARLA
 Distribuzione geografica
Continente #
NA - Nord America 15.684
EU - Europa 1.889
AS - Asia 1.338
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
AF - Africa 6
Totale 18.943
Nazione #
US - Stati Uniti d'America 15.662
CN - Cina 904
IT - Italia 592
VN - Vietnam 345
FI - Finlandia 321
SE - Svezia 292
DE - Germania 231
GB - Regno Unito 169
UA - Ucraina 163
IE - Irlanda 44
IN - India 42
FR - Francia 31
NL - Olanda 18
CA - Canada 15
HK - Hong Kong 15
RO - Romania 9
EU - Europa 8
IL - Israele 8
BZ - Belize 7
JP - Giappone 7
PE - Perù 6
PL - Polonia 5
SG - Singapore 5
TR - Turchia 5
NZ - Nuova Zelanda 4
AU - Australia 3
NO - Norvegia 3
BE - Belgio 2
BR - Brasile 2
CH - Svizzera 2
EG - Egitto 2
PH - Filippine 2
RU - Federazione Russa 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
HR - Croazia 1
IQ - Iraq 1
IR - Iran 1
MA - Marocco 1
NG - Nigeria 1
Totale 18.943
Città #
Fairfield 2.700
Woodbridge 1.652
Chandler 1.395
Houston 1.247
Ashburn 1.190
Ann Arbor 1.100
Cambridge 994
Seattle 972
Wilmington 867
Jacksonville 701
Princeton 374
Dong Ket 344
Beijing 305
San Diego 270
Padova 251
Medford 216
Des Moines 182
Roxbury 157
Helsinki 141
Nanjing 135
Boardman 107
New York 58
Shenyang 43
Dublin 41
Milan 41
Nanchang 38
Hebei 35
Guangzhou 34
Norwalk 34
London 32
Falls Church 30
Jinan 26
Jiaxing 25
Redwood City 25
Changsha 24
Tianjin 19
Dearborn 18
Zhengzhou 17
Hefei 15
Ogden 15
Rome 13
San Jose 13
Hong Kong 12
Kunming 12
Kilburn 11
Los Angeles 11
Washington 11
Borås 10
Kharkiv 10
Nürnberg 10
Pune 9
Columbus 8
Florence 8
Haikou 8
Indiana 8
Turin 8
Belize City 7
Hounslow 7
Lappeenranta 7
Chicago 6
Hangzhou 6
Naples 6
Ningbo 6
Paris 6
Pisa 6
Catania 5
Chiswick 5
Ramat Gan 5
Renton 5
Rockville 5
San Francisco 5
Vicenza 5
Albuquerque 4
Council Bluffs 4
Frankfurt am Main 4
Istanbul 4
Las Vegas 4
Lima 4
Macomer 4
Munich 4
Redmond 4
Shanghai 4
Taiyuan 4
Tappahannock 4
Treviso 4
Villavesco 4
Acton 3
Auburn Hills 3
Azzano San Paolo 3
Brendola 3
Bucharest 3
Dallas 3
Detroit 3
Dongguan 3
Foglianise 3
Herzliya 3
Iasi 3
Lanzhou 3
Legnaro 3
Montebello Vicentino 3
Totale 16.222
Nome #
A 10-year history of secondary hypertension: A challenging case of renin-secreting juxtaglomerular cell tumor 171
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155) 155
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 154
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients 154
Diagnosis and complications of Cushing's disease: gender-related differences. 147
THE NATURAL HISTORY OF AUTOIMMUNE ADDISON'S DISEASE FROM THE DETECTION OF AUTOANTIBODIES TO DEVELOPMENT OF THE DISEASE: A LONG FOLLOW-UP STUDY ON 143 PATIENTS 145
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC 142
Activation of the Dopamine Receptor Type-2 (DRD2) Promoter by 9-Cis Retinoic Acid in a Cellular Model of Cushing's Disease Mediates the Inhibition of Cell Proliferation and ACTH Secretion Without a Complete Corticotroph-to-Melanotroph Transdifferentiation 137
Unilateral adrenal tumor, erectile dysfunction and infertility in a patient with 21-hydroxylase deficiency: effects of glucocorticoid treatment and surgery 133
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor 133
Age and the metabolic syndrome affect salivary cortisol rhythm: Data from a community sample 132
Crude extract of Origanum vulgare L. induced cell death and suppressed MAPK and PI3/Akt signaling pathways in SW13 and H295R cell lines 131
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas 128
Herniation of cerebellar tonsils in acromegaly: prevalence, pathogenesis and clinical impact. 125
Perioperative multidisciplinary management of endoscopic transsphenoidal surgery for sellar lesions: practical suggestions from the Padova model 125
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up 125
The Role of Unilateral Adrenalectomy in ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH). 124
First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS 124
Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing’s disease 124
A venous thromboembolism risk assessment model for patients with Cushing’s syndrome 123
A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma 120
An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: A single-centre experience 120
Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center. 120
Aldosterone in Gynecology and Its Involvement on the Risk of Hypertension in Pregnancy 120
New insight into the Hypercoagulability of Cushing's Syndrome 117
Screening tests for cushing's syndrome: Urinary free cortisol role measured by LC-MS/MS 116
Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up. 115
Analysis of gpr101 and aip genes mutations in acromegaly: a multicentric study. 114
Early recognition of aggressive pituitary adenomas: a single-centre experience 112
Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas 111
A scoring system increases specificity of I-MIBG scan for the diagnosis of pheochromocytoma 110
Treatment of polycystic ovary syndrome with spironolactone plus licorice. 110
Improved salivary cortisol rhythm with dual-release hydrocortisone 109
The medical treatment with pasireotide in Cushing's disease: an Italian multicentre experience based on "real-world evidence" 109
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 109
Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate 108
Combination therapy for Cushing's disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole? 108
Metyrapone treatment in Cushing’s syndrome: a real-life study 108
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 108
Intracranial internal carotid artery changes in acromegaly: a quantitative magnetic resonance angiography study. 107
HLA and hormonal studies in 5 patients with late-onset 21-hydroxylase deficiency syndrome (21OHDS). 106
Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. 104
Diagnostic performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma and adrenal insufficiency. 104
Medical Treatment for Acromegaly does not Increase the Risk of Central Adrenal Insufficiency: A Long-Term Follow-Up Study 102
Food-dependent Cushing's syndrome: from molecular characterization to therapeutical results 100
The diagnostic performance of urinary free cortisol is better than the cortisol:cortisone ratio in detecting de novo Cushing's syndrome: the use of a LC-MS/MS method in routine clinical practice 100
Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency 100
Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation 100
Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia. 99
Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth? 99
Adrenal nodules in patients with Cushing's disease: prevalence, clinical significance and follow-up. 99
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group. 98
Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study 98
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 97
Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome 97
Gonadotropin secreting pituitary adenoma associated with erythrocytosis: case report and literature review. 95
Different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia 95
PTH: Redefining Reference Ranges in a Healthy Population-The Role of Interfering Factors and the Type of Laboratory Assay 95
Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly 94
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 94
Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma 94
The effects of iodine supplementation in pregnancy on iodine status, thyroglobulin levels and thyroid function parameters: Results from a randomized controlled clinical trial in a mild-to-moderate iodine deficiency area 94
Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury 93
Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome 93
Conventional and nuclear medicine imaging in Ectopic Cushing's syndrome: A systematic review 93
Furosemide and 11beta-hydroxysteroid dehydrogenase activity, in man. 92
Inhibitory effect of somatostatin on the aldosterone response to angiotensin II: in vitro studies. 92
Investigation of N-cadherin/β-catenin expression in adrenocortical tumors 92
Clinical presentation and management of acromegaly in elderly patients 92
Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. 91
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line 91
Efficacy and safety of high-dose long-acting repeatable octreotide as monotherapy or in combination with pegvisomant or cabergoline in patients with acromegaly not adequately controlled by conventional regimens: results of an open-label, multicentre study 91
Increased rate of intracranial saccular aneurysms in acromegaly: an MR angiography study and review of the literature. 91
The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome 90
The R304X mutation of the Aryl hydrocarbon receptor Interacting Protein gene in familial isolated pituitary adenomas: mutational Hot-Spot or founder effect? 89
Potential Role for Retinoic Acid in Patients with Cushing's Disease. 89
New insights to the potential mechanisms driving coronary flow reserve impairment in Cushing's syndrome: A pilot noninvasive study by transthoracic Doppler echocardiography 89
Hypercortisolism and pregnancy upregulate von Willebrand factor through different mechanisms: report on a pregnant patient with Cushing's syndrome. 89
A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype 88
Therapeutic strategies for Cushing's syndrome: An update 88
Unilateral adrenal tumor, erectile dysfunction and infertility in a patient with 21-hydroxylase deficiency: effects of glucocorticoid treatment 87
The glucose-dependent insulinotropic polypeptide receptor (GIPR) is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives GH-promoter activity in GH3 cells. 87
LOW-DOSE KETOCONAZOLE TREATMENT IN HIRSUTE WOMEN 87
Retinal abnormalities associated with a mutation of the nucleotide 683 in von Hippel-Lindau disease 86
Secondary Arterial Hypertension: From Routine Clinical Practice to Evidence in Patients with Adrenal Tumor 86
The body fat mass and extracellular water changes: effect of licorice in human 85
Acromegaly is associated with increased cancer risk: a survey in Italy 85
Radiotherapy in acromegaly: Long-term brain parenchymal and vascular magnetic resonance changes 85
Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients 85
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH dependent Cushing's syndrome 84
Predicting late recurrence in surgically-treated patients with Cushing's disease. 84
Steroids and Hypertension 84
The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging 83
Risk factors and long-term follow-up of adrenal incidentalomas 83
Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile. 82
No linkage between HLA and congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency. 81
Cardiovascular autonomic dysfunction in patients with idiopathic diabetes insipidus 81
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 81
The M235T polymorphism of the angiotensinogen gene in women with polycystic ovary syndrome 80
Glucose metabolism abnormalities in Cushing's syndrome: from molecular basis to clinical management 80
Totale 10.456
Categoria #
all - tutte 70.214
article - articoli 66.429
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 648
Totale 137.291


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.264 0 0 0 0 0 0 0 0 0 254 540 470
2019/20204.191 454 148 64 408 419 286 404 458 546 442 335 227
2020/20213.441 191 247 203 229 112 183 139 275 456 353 393 660
2021/20223.801 130 401 426 278 251 248 185 424 184 98 350 826
2022/20232.776 631 357 37 342 401 353 13 185 283 25 118 31
2023/20241.249 55 201 177 134 157 183 167 98 41 36 0 0
Totale 19.355